DANAHER CORPORATION Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted
DANAHER CORPORATION (DHR) reported Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted of $3.90 billion for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-20.
Financial Statements › Income Statement › Other Income
us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted · last filed 2025-02-20
- DANAHER CORPORATION net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2024-12-31 was $1.09B, a 3.12% decline year-over-year.
- DANAHER CORPORATION net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2024-09-27 was $818.00M, a 12.98% decline year-over-year.
- DANAHER CORPORATION net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2024-06-28 was $907.00M, a 1.41% decline year-over-year.
- DANAHER CORPORATION net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2024-03-29 was $1.09B, a 10.75% decline year-over-year.
- DANAHER CORPORATION net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2024 was $3.90B, a 7.17% decline from fiscal 2023.
- DANAHER CORPORATION net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2023 was $4.20B, a 32.71% decline from fiscal 2022.
- DANAHER CORPORATION net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2022 was $6.24B, a 16.43% increase from fiscal 2021.
- DANAHER CORPORATION net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2021 was $5.36B, a 52.69% increase from fiscal 2020.
| Period end | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 3 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 3 month as first filed | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 6 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 6 month as first filed | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 9 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 9 month as first filed | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 12 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $1.09B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $1.90B derived: sum of 2 quarters · filed 2025-02-20 | $2.81B derived: sum of 3 quarters · filed 2025-02-20 | $3.90B 10-K · filed 2025-02-20 | ||||
| 2024-09-27 | $818.00M 10-Q · filed 2024-10-22 | $1.73B derived: sum of 2 quarters · filed 2024-10-22 | $2.81B 10-Q · filed 2024-10-22 | $3.93B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2024-06-28 | $907.00M 10-Q · filed 2024-07-23 | $2.00B 10-Q · filed 2024-07-23 | $3.12B derived: sum of 3 quarters · filed 2025-02-20 | $4.06B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2024-03-29 | $1.09B 10-Q · filed 2024-04-23 | $2.21B derived: sum of 2 quarters · filed 2025-02-20 | $3.15B derived: sum of 3 quarters · filed 2025-02-20 | $4.07B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-12-31 | $1.12B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $2.06B derived: sum of 2 quarters · filed 2025-02-20 | $2.98B derived: sum of 3 quarters · filed 2025-02-20 | $4.20B 10-K · filed 2025-02-20 | ||||
| 2023-09-29 | $940.00M 10-Q · filed 2024-10-22 | $1.86B derived: sum of 2 quarters · filed 2024-10-22 | $3.08B 10-Q · filed 2024-10-22 | $4.41B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $920.00M 10-Q · filed 2024-07-23 | $2.14B 10-Q · filed 2024-07-23 | $3.47B derived: sum of 3 quarters · filed 2025-02-20 | $5.02B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $1.22B 10-Q · filed 2024-04-23 | $2.55B derived: sum of 2 quarters · filed 2025-02-20 | $4.10B derived: sum of 3 quarters · filed 2025-02-20 | $5.76B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $1.33B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $2.88B derived: sum of 2 quarters · filed 2025-02-20 | $4.54B derived: sum of 3 quarters · filed 2025-02-20 | $6.24B 10-K · filed 2025-02-20 | $7.12B 10-K · filed 2023-02-22 | |||
| 2022-09-30 | $1.55B 10-Q · filed 2022-10-20 | $3.21B derived: sum of 2 quarters · filed 2022-10-20 | $4.91B 10-Q · filed 2022-10-20 | |||||
| 2022-07-01 | $1.66B 10-Q · filed 2022-07-21 | $3.36B 10-Q · filed 2022-07-21 | ||||||
| 2021-12-31 | $866.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $1.98B derived: sum of 2 quarters · filed 2024-02-21 | $3.66B derived: sum of 3 quarters · filed 2024-02-21 | $5.36B 10-K · filed 2024-02-21 | $6.26B 10-K · filed 2022-02-23 | |||
| 2021-10-01 | $1.12B 10-Q · filed 2022-10-20 | $2.79B derived: sum of 2 quarters · filed 2022-10-20 | $4.50B 10-Q · filed 2022-10-20 | |||||
| 2021-07-02 | $1.68B 10-Q · filed 2022-07-21 | $3.36B 10-Q · filed 2022-07-21 | ||||||
| 2020-12-31 | $1.20B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $2.04B derived: sum of 2 quarters · filed 2023-02-22 | $2.94B derived: sum of 3 quarters · filed 2023-02-22 | $3.51B 10-K · filed 2023-02-22 | ||||
| 2020-10-02 | $842.00M 10-Q · filed 2021-10-21 | $842.70M 10-Q · filed 2020-10-22 | $1.74B derived: sum of 2 quarters · filed 2021-10-21 | $2.31B 10-Q · filed 2021-10-21 | $2.31B 10-Q · filed 2020-10-22 | $3.08B derived: sum of 4 quarters · filed 2022-02-23 | ||
| 2020-07-03 | $893.00M 10-Q · filed 2021-07-22 | $1.47B 10-Q · filed 2021-07-22 | $1.47B 10-Q · filed 2020-07-23 | $2.24B derived: sum of 3 quarters · filed 2022-02-23 | $2.85B derived: sum of 4 quarters · filed 2022-02-23 | |||
| 2020-04-03 | $575.80M 10-Q · filed 2020-05-06 | $1.35B derived: sum of 2 quarters · filed 2022-02-23 | $1.96B derived: sum of 3 quarters · filed 2022-02-23 | $2.62B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $774.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $1.39B derived: sum of 2 quarters · filed 2022-02-23 | $2.04B derived: sum of 3 quarters · filed 2022-02-23 | $2.37B 10-K · filed 2022-02-23 | $2.37B 10-K · filed 2020-02-21 | |||
| 2019-09-27 | $611.50M 10-Q · filed 2020-10-22 | $1.27B derived: sum of 2 quarters · filed 2020-10-22 | $1.59B 10-Q · filed 2020-10-22 | |||||
| 2019-06-28 | $654.20M 10-Q · filed 2020-07-23 | $980.50M 10-Q · filed 2020-07-23 | ||||||
| 2019-03-29 | $326.30M 10-Q · filed 2020-05-06 | |||||||
| 2018-12-31 | $2.41B 10-K · filed 2021-02-25 | $2.41B 10-K · filed 2020-02-21 | ||||||
| 2017-12-31 | $2.17B 10-K · filed 2020-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keysight Technologies, Inc. (KEYS) | United States | $60.876B | 51.86 |
| AMETEK INC/ (AME) | United States | $56.772B | 35.17 |
| ROPER TECHNOLOGIES INC (ROP) | United States | $36.012B | 13.63 |
| MKS INC (MKSI) | United States | $17.440B | 68.37 |
| Fortive Corp (FTV) | United States | $16.897B | 31.51 |
| COGNEX CORP (CGNX) | United States | $9.711B | 65.26 |
| Ralliant Corp (RAL) | United States | $7.737B | -6.14 |
| Sensata Technologies Holding plc (ST) | $5.976B | 77.15 | |
| MESA LABORATORIES INC /CO/ (MLAB) | United States | $0.768B | 116.22 |
| Senseonics Holdings, Inc. (SENS) | United States | $0.546B | -2.74 |